Abstract: A holder for a surface contact card includes a first housing, a second housing, and a tray. The first housing defines a receiving hole. The second housing includes a cover portion. A tray is configured for carrying a surface contact card therein. The cover portion covers one part of the tray. The tray slidably engages in the receiving hole allowing insertion and removal of the surface contact card from inside the first housing and the second housing.

Abstract: A housing assembly for a portable electronic device includes a shell including a supporting portion, a frame, and a latching member. The latching member includes a body portion, at least one positioning portion and at least one bent portion. The body portion is disposed on the shell. The positioning portion is secured in the shell. The bent portion engages the frame. The supporting portion of the shell resists the positioning portion of the latching member.

Abstract: A chip card holder is configured for receiving a chip card. The chip card holder includes a housing defining a groove, a latching part received in the groove, a fixing element made of rubber material. The chip card is received in the latching part. The fixing element includes a main plate, a positioning portion, a rib, and a free end. The positioning portion is positioned on a side of the main plate. The positioning portion latches the housing. The rib is positioned on the same side which positioning the positioning portion. The rib resists the chip card. The free end extends from a peripheral edge of the main plate. The present disclosure further discloses an electronic device using the chip card holder.

Abstract: The present invention relates to novel methods and devices for differentiating in a patient parathyroid diseases, such as hyperparathyroidism and related bone diseases, from normal or non-disease states. One detects whole or non-fragmented (1 to 84) parathyroid hormone in a biological sample and also a large non-whole parathyroid hormone peptide fragment that can function as a parathyroid hormone antagonist. By either comparing values or using independently the value of either the large non-whole parathyroid hormone peptide fragment, the whole parathyroid hormone, or the combination of these values one is able to differentiate parathyroid and bone related disease states, as well as differentiate such states from normal states.

Abstract: The present invention relates to novel methods and devices for differentiating in a patient parathyroid diseases, such as hyperparathyroidism and related bone diseases, from normal or non-disease states. One detects whole or non-fragmented (1 to 84) parathyroid hormone in a biological sample and also a large non-whole parathyroid hormone peptide fragment that can function as a parathyroid hormone antagonist.

Abstract: The present invention relates to novel methods and compositions useful for detecting whole parathyroid hormone at a physiological level and parathyroid fragments in a mammalian sample. Such detections may be useful to different parathyroid diseases or disorders in a subject, such as hyperparathyroidism and related bone diseases, from normal or non-disease states. One detects whole or non-fragmented (1 to 84) parathyroid hormone in a biological sample and optionally one or more of a selection of non-whole parathyroid hormone peptide fragments that may or may not function as a parathyroid hormone antagonists. By either comparing values or using independently the value of either the one or more of a selection of non-whole parathyroid hormone peptide fragments, the whole parathyroid hormone, or the combination of these values one is able to differentiate parathyroid and bone related disease states, as well as differentiate such states from normal states.

Abstract: The invention relates to a process for making a carbon nanotubes/ultra-high molar mass polyethylene (CNTs/UHPE) composite fiber comprising the steps of a) pre-treating CNTs with an acidic aqueous solution; b) making a composition containing pre-treated CNTs dispersed in a solution of UHPE in a spin solvent; and c) spinning the composition obtained into fibers; wherein step b) comprises making a dispersion of pre-treated CNTs in an alcohol, and mixing this dispersion with a mixture of UHPE and spin solvent. With this process CNTs/UHPE composite fibers showing improved tensile properties are obtained at relatively low CNTs content. A further advantage is that no or hardly any additional components, like dispersion aids, need to be added to make a stable dispersion of CNTs in the spin composition. The invention also relates to a CNTs/UHPE composite fiber obtainable by the process according to the invention, and to semi-finished or end-use articles containing said composite fiber.

Abstract: The present invention includes devices and methods for the detection of an analyte in a fecal sample. The fecal sample test device includes a sample collection structure and sample collection housing, a detection housing, a fecal suspension solution or fecal dilution solution, a detection housing capable of attachment to the collection housing and an analyte detecting means. When attached, the collection housing permits a portion of liquid extracted sample to fluidly flow into the detection housing where the analyte detection means detects the presence or quantity of an analyte suspected of being present in the fecal sample.

Abstract: The present invention relates to the use of control compositions and kits comprising such to evaluate and monitor the consistency of assays utilized to determine parathyroid hormone levels.

Abstract: The present invention relates to novel methods and devices for differentiating in a patient parathyroid diseases, such as hyperparathyroidism and related bone diseases, from normal or non-disease states. One detects whole or non-fragmented (1 to 84) parathyroid hormone in a biological sample and also a large non-whole parathyroid hormone peptide fragment that can function as a parathyroid hormone antagonist. By either comparing values or using independently the value of either the large non-whole parathyroid hormone peptide fragment, the whole parathyroid hormone, or the combination of these values one is able to differentiate parathyroid and bone related disease states, as well as differentiate such states from normal states.

Abstract: The component of magnesium halide adduct is represented by MgX2 mROH nE pH2O, in which X is chlorine, bromine, C1-C14alkoxy or aryloxy; R is C1-C12 alkyl, C3-C10 cycloalkyl or C6-C10 aryl; E is represented by the general formula (II), wherein R1 and R2 which can be the same or different to each other, are hydrogen or linear or branched C1-C10 hydrocarbon groups, C3-C10 cycloalkyl, C6-C10 aryl, C7-C10 alkaryl or aralkyl, optionally, the said aryl or alkylaryl or arylalkyl is substituted by one or more halogen in the aromatic ring, R1 and R2 can form ring or fused ring. R3 and R4 have the same meaning of R1 and R2 except that they can't be hydrogen, m is 1-5, n is 0.005-1.0, and p is 0-0.8. Spherical catalyst component and catalyst made from the above spherical magnesium halide adduct and their use in polymerising the alpha-olefins CH2=CHR and their mixture are provided, in which R is hydrogen or C1-C12 alkyl or aryl.

Abstract: A battery connector has an insulative housing, a plurality of terminals and a holding bracket. The terminals are mounted in the insulative housing and each terminal has a contacting portion extending out of the insulative housing. The holding bracket covers the insulative housing and has a top portion, two side portions and two protective portions. The protective portions are formed on and protrudes forwards respectively from the side portions and extend forwards relative to the front of the insulative housing. The terminals are protected by the protective portions and would not permanently deformed by a battery pressing against the terminals.

Abstract: The present invention relates to the use of control compositions and kits comprising such to evaluate and monitor the consistency of assays utilized to determine parathyroid hormone levels.

Abstract: A battery connector has an insulative housing, a plurality of terminals and a holding bracket. The terminals are mounted in the insulative housing and each terminal has a contacting portion extending out of the insulative housing. The holding bracket covers the insulative housing and has a top portion, two side portions and two protective portions. The protective portions are formed on and protrudes forwards respectively from the side portions and extend forwards relative to the front of the insulative housing. The terminals are protected by the protective portions and would not permanently deformed by a battery pressing against the terminals.

Abstract: The present invention relates to the use of control compositions and kits comprising such to evaluate and monitor the consistency of assays utilized to determine parathyroid hormone levels.

Abstract: A method is described for treating fabrics, yarns and individual fibers to improve the mechanical properties thereof, for example their wrinkle-resistance, by treating the fabric, yarn, and fibers in a solution containing polymer nanoparticles. The nanoparticles include two sizes of particles and an appropriate selection of the nanoparticles to control the degree and mode of cross-linking in the fabric with corresponding control of the mechanical properties. The nanoparticles can be provided with an electrical charge that can be opposite in sign to any charge carried by the fabric in order to enhance the formation of a polymer film on the fabric.

Abstract: The invention relates to a process for making a carbon nanotubes/ultra-high molar mass polyethylene (CNTs/UHPE) composite fibre comprising the steps of a) pre-treating CNTs with an acidic aqueous solution; b) making a composition containing pre-treated CNTs dispersed in a solution of UHPE in a spin solvent; and c) spinning the composition obtained into fibres; wherein step b) comprises making a dispersion of pre-treated CNTs in an alcohol, and mixing this dispersion with a mixture of UHPE and spin solvent. With this process CNTs/UHPE composite fibres showing improved tensile properties are obtained at relatively low CNTs content. A further advantage is that no or hardly any additional components, like dispersion aids, need to be added to make a stable dispersion of CNTs in the spin composition. The invention also relates to a CNTs/UHPE composite fibre obtainable by the process according to the invention, and to semi-finished or end-use articles containing said composite fibre.

Abstract: The present invention relates to novel methods and compositions useful for detecting whole parathyroid hormone at a physiological level and parathyroid fragments in a mammalian sample. Such detections may be useful to different parathyroid diseases or disorders in a subject, such as hyperparathyroidism and related bone diseases, from normal or non-disease states. One detects whole or non-fragmented (1 to 84) parathyroid hormone in a biological sample and optionally one or more of a selection of non-whole parathyroid hormone peptide fragments that may or may not function as a parathyroid hormone antagonists. By either comparing values or using independently the value of either the one or more of a selection of non-whole parathyroid hormone peptide fragments, the whole parathyroid hormone, or the combination of these values one is able to differentiate parathyroid and bone related disease states, as well as differentiate such states from normal states.

Abstract: A method, data processing system, and computer program product are provided for performing time-based symbolic simulation. A delay-aware representation of a circuit is created that includes a plurality of circuit nodes. The data-aware representation is simulated. In particular, the simulator simulates transitions from a first set of circuit nodes to a second set of circuit nodes selected from the plurality of circuit nodes, the simulating based on executing a first set of simulation events. A second set of simulation events is then generated in response to executing the first set of simulation events. During the simulation, a time is computed for each of the transitions. An an event scheduling diagram is constructed during simulation. The event scheduling diagram depicts the transitions and the times of the transitions.

Abstract: The present invention relates to novel methods and compositions useful for detecting whole parathyroid hormone at a physiological level and parathyroid fragments in a mammalian sample. Such detections may be useful to different parathyroid diseases or disorders in a subject, such as hyperparathyroidism and related bone diseases, from normal or non-disease states. One detects whole or non-fragmented (1 to 84) parathyroid hormone in a biological sample and optionally one or more of a selection of non-whole parathyroid hormone peptide fragments that may or may not function as a parathyroid hormone antagonists. By either comparing values or using independently the value of either the one or more of a selection of non-whole parathyroid hormone peptide fragments, the whole parathyroid hormone, or the combination of these values one is able to differentiate parathyroid and bone related disease states, as well as differentiate such states from normal states.